- Edoxaban - new FXa inhibitor2017 | Publication without faculty affiliation
- Andexanet alfa - specific antidote to severe bleeding after a treatment with apixaban or rivaroxaban2020 | Publication without faculty affiliation
- Where is a step in the current development of drugs that affect blood clotting?2012 | First Faculty of Medicine
- Clinical use of the new antithrombotics2010 | Faculty of Medicine in Hradec Králové